On February 26, 2026, at the ASCO GU 2026 Conference in San Francisco, California, ImmVira Group announced preliminary positive results from its clinical trial evaluating MVR-T3011, an oncolytic virus ...
Experts from the Translational Research in Neuroimaging and Data Science (TReNDS) Center at Georgia State University will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results